ITMI912652A1 - ANTIELASTASIC ACTIVITY MEDICATION. - Google Patents

ANTIELASTASIC ACTIVITY MEDICATION.

Info

Publication number
ITMI912652A1
ITMI912652A1 IT002652A ITMI912652A ITMI912652A1 IT MI912652 A1 ITMI912652 A1 IT MI912652A1 IT 002652 A IT002652 A IT 002652A IT MI912652 A ITMI912652 A IT MI912652A IT MI912652 A1 ITMI912652 A1 IT MI912652A1
Authority
IT
Italy
Prior art keywords
antielastasic
medication
activity
activity medication
antielastasic activity
Prior art date
Application number
IT002652A
Other languages
Italian (it)
Inventor
Gerardo Bernasconi
Original Assignee
Golgi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golgi Sa filed Critical Golgi Sa
Priority to ITMI912652A priority Critical patent/IT1251615B/en
Publication of ITMI912652A0 publication Critical patent/ITMI912652A0/en
Priority to PCT/EP1992/002269 priority patent/WO1993006823A1/en
Priority to EP92920465A priority patent/EP0565658A1/en
Priority to JP5506603A priority patent/JPH06506500A/en
Priority to AU26644/92A priority patent/AU2664492A/en
Priority to CA002097611A priority patent/CA2097611A1/en
Publication of ITMI912652A1 publication Critical patent/ITMI912652A1/en
Application granted granted Critical
Publication of IT1251615B publication Critical patent/IT1251615B/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITMI912652A 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION. IT1251615B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI912652A IT1251615B (en) 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION.
PCT/EP1992/002269 WO1993006823A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema
EP92920465A EP0565658A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema
JP5506603A JPH06506500A (en) 1991-10-04 1992-09-30 Verbenone with anti-elastase activity against emphysema
AU26644/92A AU2664492A (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema
CA002097611A CA2097611A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase actibity, against pulmonary emphysema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912652A IT1251615B (en) 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION.

Publications (3)

Publication Number Publication Date
ITMI912652A0 ITMI912652A0 (en) 1991-10-04
ITMI912652A1 true ITMI912652A1 (en) 1993-04-04
IT1251615B IT1251615B (en) 1995-05-17

Family

ID=11360822

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912652A IT1251615B (en) 1991-10-04 1991-10-04 ANTIELASTASIC ACTIVITY MEDICATION.

Country Status (6)

Country Link
EP (1) EP0565658A1 (en)
JP (1) JPH06506500A (en)
AU (1) AU2664492A (en)
CA (1) CA2097611A1 (en)
IT (1) IT1251615B (en)
WO (1) WO1993006823A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157446B2 (en) * 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
ES2673853T3 (en) * 2012-06-05 2018-06-26 Korea University Research And Business Foundation Pharmaceutical composition containing a verbenone derivative to treat or prevent a neurodegenerative disease
CN113603802B (en) * 2021-08-24 2022-10-14 华侨大学 Preparation method and application of verbena polysaccharide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH625197A5 (en) * 1976-06-03 1981-09-15 Buskine Sa Process for preparing verbenone, myrtenal and pinocarveol
EP0491812A4 (en) * 1989-09-14 1992-11-04 Australian Commercial Research & Development Limited Drug delivery compositions

Also Published As

Publication number Publication date
WO1993006823A1 (en) 1993-04-15
CA2097611A1 (en) 1993-04-04
ITMI912652A0 (en) 1991-10-04
AU2664492A (en) 1993-05-03
IT1251615B (en) 1995-05-17
JPH06506500A (en) 1994-07-21
EP0565658A1 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
ITRM930334A0 (en) HAVE ANTI-CANCER ACTIVITY.
MX9102473A (en) PHARMACEUTICAL AGENTS.
FI921060A0 (en) PHARMACEUTICAL AEROSOLFORMULERINGAR.
FI922958A0 (en) PHARMACEUTICAL SAMMANSAETTNING.
FI922252A0 (en) PHARMACEUTICAL SAMMANSAETTNING.
FI922316A0 (en) PHARMACEUTICAL SAMMANSAETTNING.
DE59102292D1 (en) CATHETER.
FI923581A0 (en) PHARMACEUTICAL COMBINATIONSFORMATION.
IT8520973A0 (en) BENZOIL-UREE WITH INSECTICIDE ACTIVITY.
IT8919029A0 (en) COMPOUNDS WITH ANTISEROTONIN ACTIVITY.
IT9019754A0 (en) PHARMACEUTICAL, DIETETICAL OR VETERINARY COMPOSITIONS WITH EUMETABOLIC ACTIVITY
FI910254A (en) ORALT ACTIVE RENININHIBITORER.
FR2676557B3 (en) COMPUTER CASE.
IT1208512B (en) BENZOIL-UREE WITH INSECTICIDE ACTIVITY.
IT8819791A0 (en) PEPTIDES WITH PHARMACEUTICAL ACTIVITY.
FI915142A0 (en) ACTIVE BULLERDAEMPNINGSSYSTEM.
ITMI912652A1 (en) ANTIELASTASIC ACTIVITY MEDICATION.
FI920158A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV 3'-FLUORPYRIMIDINNUKLEOSIDER.
IT8819790A0 (en) PEPTIDES WITH PHARMACEUTICAL ACTIVITY.
FI921756A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV 4'-DEMETYLIEPIPODOFYLLOTOXIN GLUKOSID 4'-FOSFATER.
MX9201791A (en) MEDICINES.
ITMI911344A0 (en) PHARMACEUTICAL ASSOCIATION WITH ANTINEOPLASTIC ACTIVITY
FR2677788B1 (en) BILLBOARD.
FR2667779B1 (en) APN2E DIRECT MONITOR.
IT8821431A0 (en) COMPOUNDS WITH FUNGICICAL ACTIVITY.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029